Thema
Journal Article
8
615
6
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
6
Antibodies, Viral
6
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
6
Spike Glycoprotein, Coronavirus
6
che
6
Antibodies, Neutralizing
5
Research Support, Non-U.S. Gov't
5
spike
4
receptor
3
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
2
APN
2
Epitopes
2
MERS-CoV
2
PDCoV
2
Receptors, Virus
2
Viral Vaccines
2
cross-species transmission
2
570
1
Allergens
1
Animal model
1
Antibodies, Monoclonal
1
Antibodies, Monoclonal, Humanized
1
Antigens, CD1
1
Biology
1
CCR7
1
CCR7 protein, human
1
CD13 Antigens
1
CD1C protein, human
1
CRLF2 protein, human
1
Coronavirus
1
Cytokines
1
Dipeptidyl Peptidase 4
1
EC 3.4.11.2
1
EC 3.4.14.5
1
GT0IL38SP4
1
Glycoproteins
1
MERS
1
MERS-coronavirus
1
Middle East respiratory syndrome coronavirus
1
Mucins
1
Polysaccharides
1
Protein Subunits
1
Receptors, CCR7
1
Receptors, Cytokine
1
Research Support, N.I.H., Extramural
1
S1-protein-based vaccine
1
SARS-CoV-2
1
Sialic Acids
1
mehr ...